For example, in considering approaches to studying a single major disease gene, the p53 tumour suppressor protein (encoded by the TRP53 gene) is mutated in ~ 50% human cancers, and the remaining 50% usually carry mutations that inactivate the p53 pathway; thus, there has been interest in reactivating p53 as a treatment for cancer [58]. This evidence concerns the gene TP53 and cancer.